3-Year Outcomes of Balloon-Expandable&#xa0;Valves: 20-mm vs Larger Valves (&#x2265;23&#xa0;mm)

Heart, Artery and Coronary DiseasesTherapy and Intervention

Asymmetrical Expansion of Balloon-Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamic and Clinical Outcomes

JACC Cardiovasc Interv

Maznyczka A, Heg D, Tomii D, Nakase M, Baekke PS, Lanz J, Stortecky S, Reineke D, Windecker S, Pilgrim T

doi: 10.1016/j.jcin.2024.05.039

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Tricuspid Regurgitation on Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves

JACC Cardiovasc Interv

Zahr F, Elmariah S, Vemulapalli S, Kodali SK, Hahn RT, Anderson AS, Eleid MF, Davidson CJ, Sharma RP, O'Neill WW, Bethea B, Thourani VH, Chakravarty T, Gupta A, Makkar RR

doi: 10.1016/j.jcin.2024.07.005

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥ Intermediate Risk

J Am Coll Cardiol

Yakubov SJ, Van Mieghem NM, Oh JK, Ito S, Grubb KJ, O'Hair D, Forrest JK, Gada H, Mumtaz M, Deeb GM, Tang GHL, Rovin JD, Jain R, Windecker S, Skelding KA, Kleiman NS, Chetcuti SJ, Dedrick A, Boatman SV, Popma JJ, Reardon MJ

doi: 10.1016/j.jacc.2025.02.009

Heart, Artery and Coronary DiseasesTherapy and Intervention

Five-Year Outcomes with Self-expanding versus Balloon-expandable TAVI in Patients with Left Ventricular Systolic Dysfunction

Am Heart J

Nakase M, Tomii D, Maznyczka A, Heg D, Okuno T, Samim D, Stortecky S, Lanz J, Reineke D, Windecker S, Pilgrim T

doi: 10.1016/j.ahj.2024.10.018

Heart, Artery and Coronary DiseasesTherapy and Intervention

Effect of Valve Type and Anesthesia Strategy for TAVR: 5-Year Results of the SOLVE-TAVI Trial

J Am Coll Cardiol

Feistritzer HJ, Kurz T, Vonthein R, Schröder L, Stachel G, Eitel I, Marquetand C, Saraei R, Kirchhof E, Heringlake M, Abdel-Wahab M, Desch S, Thiele H, SOLVE-TAVI Investigators

doi: 10.1016/j.jacc.2024.09.007

Heart, Artery and Coronary DiseasesTherapy and Intervention

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

J Am Coll Cardiol

Forrest JK, Yakubov SJ, Deeb GM, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Crouch J, Merhi W, Wai Sang SL, Kleiman NS, Petrossian G, Robinson NB, Sorajja P, Iskander A, Berthoumieu P, Tchétché D, Feindel C, Horlick EM, Saito S, Oh JK, Jung Y, Reardon MJ, Low Risk Trial Investigators

doi: 10.1016/j.jacc.2025.03.004

Thrombosis and Stroke

Plain versus drug balloon and stenting in severe ischaemia of the leg (BASIL-3): open label, three arm, randomised, multicentre, phase 3 trial

BMJ

Bradbury AW, Hall JA, Popplewell MA, Meecham L, Bate GR, Kelly L, Deeks JJ, Moakes CA, BASIL-3 Investigators

doi: 10.1136/bmj-2024-080881

Heart, Artery and Coronary DiseasesTherapy and Intervention

Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement: FRANCE 2 and FRANCE TAVI Registries

J Am Coll Cardiol

Durand E, Eltchaninoff H, Tchetche D, Levesque T, Garmendia C, Iung B, Benamer H, Cayla G, Van Belle E, Commeau P, Le Breton H, Cuisset T, Akodad M, Verhoye JP, Beurtheret S, du Chayla F, Leclere M, Gilard M, Dumonteil N, STOP-AS and France TAVI Investigators

doi: 10.1016/j.jacc.2024.11.048

Heart, Artery and Coronary DiseasesTherapy and Intervention

Early Outcomes From a Multicenter Transcatheter Self-Expanding Pulmonary Valve Replacement Registry

J Am Coll Cardiol

Goldstein BH, McElhinney DB, Gillespie MJ, Aboulhosn JA, Levi DS, Morray BH, Cabalka AK, Love BA, Zampi JD, Balzer DT, Law MA, Schiff MD, Hoskoppal A, Qureshi AM

doi: 10.1016/j.jacc.2024.02.010

Cardiovascular

3-Year Outcomes of Balloon-Expandable Valves: 20-mm vs Larger Valves (≥23 mm)

Related content

Asymmetrical Expansion of Balloon-Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamic and Clinical Outcomes

Impact of Tricuspid Regurgitation on Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves

Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥ Intermediate Risk

Five-Year Outcomes with Self-expanding versus Balloon-expandable TAVI in Patients with Left Ventricular Systolic Dysfunction

Effect of Valve Type and Anesthesia Strategy for TAVR: 5-Year Results of the SOLVE-TAVI Trial

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

Plain versus drug balloon and stenting in severe ischaemia of the leg (BASIL-3): open label, three arm, randomised, multicentre, phase 3 trial

Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement: FRANCE 2 and FRANCE TAVI Registries

Early Outcomes From a Multicenter Transcatheter Self-Expanding Pulmonary Valve Replacement Registry